FDMT Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . 4D Molecular Therapeutics
FDMT Stock  USD 3.82  0.36  8.61%   
4D Molecular financial statements provide useful quarterly and yearly information to potential 4D Molecular Therapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on 4D Molecular financial statements helps investors assess 4D Molecular's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting 4D Molecular's valuation are summarized below:
Gross Profit
-141.3 M
Market Capitalization
193.5 M
Enterprise Value Revenue
8.5715
Revenue
37 K
Earnings Share
(2.98)
There are currently one hundred twenty fundamental measures for 4D Molecular that can be evaluated and compared over time across peers in the sector. All traders should validate 4D Molecular's latest fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 285.4 M in 2025. Enterprise Value is likely to drop to about 166.9 M in 2025

4D Molecular Total Revenue

35,150

Check 4D Molecular financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 4D Molecular's main balance sheet or income statement drivers, such as Net Interest Income of 28.4 M, Interest Income of 28.4 M or Depreciation And Amortization of 4.2 M, as well as many indicators such as Price To Sales Ratio of 8.5 K, Dividend Yield of 0.0 or PTB Ratio of 0.62. FDMT financial statements analysis is a perfect complement when working with 4D Molecular Valuation or Volatility modules.
  
Check out the analysis of 4D Molecular Correlation against competitors.

4D Molecular Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets588.4 M560.4 M172.9 M
Slightly volatile
Other Current Liabilities19.8 M18.9 M5.7 M
Slightly volatile
Total Current Liabilities17 M29.1 M11.4 M
Slightly volatile
Other Liabilities1.1 M1.2 M14.5 M
Slightly volatile
Property Plant And Equipment Net20.9 M40.6 M12 M
Slightly volatile
Current Deferred Revenue244.2 K257 K3.5 M
Slightly volatile
Accounts Payable2.9 M4.4 M1.7 M
Slightly volatile
Cash189 M149.3 M108.2 M
Slightly volatile
Non Current Assets Total131.7 M125.5 M26 M
Slightly volatile
Other Assets640.8 K1.2 M449.5 K
Slightly volatile
Cash And Short Term Investments232.3 M424.9 M130.5 M
Slightly volatile
Net Receivables620.8 K630 K553.4 K
Slightly volatile
Common Stock Total Equity2.2 K3.5 K1.7 K
Slightly volatile
Common Stock Shares Outstanding32.1 M53.9 M23.1 M
Slightly volatile
Non Current Liabilities Total35.8 M20.6 M42.5 M
Pretty Stable
Other Current Assets6.3 M10.1 M3.4 M
Slightly volatile
Other Stockholder Equity1.1 B1.1 B259 M
Slightly volatile
Total Liabilities47.3 M49.8 M86.4 M
Pretty Stable
Property Plant And Equipment Gross60.1 M57.2 M17 M
Slightly volatile
Total Current Assets236.7 M434.9 M133.1 M
Slightly volatile
Non Current Liabilities Other183.3 K193 K2.4 M
Slightly volatile
Net Working Capital211.5 M405.8 M117.5 M
Slightly volatile
Short Term Debt3.1 M5.6 M1.6 M
Slightly volatile
Common Stock2.9 K5 K1.9 K
Slightly volatile
Property Plant Equipment26.9 M25.6 M10 M
Slightly volatile
Capital Stock3.1 K5 K1.9 K
Slightly volatile
Capital Surpluse537.4 M629.1 M443.7 M
Slightly volatile
Deferred Long Term Liabilities200.9 K243.8 K151.5 K
Slightly volatile
Short and Long Term Debt Total19.8 M24.6 M17 M
Slightly volatile

4D Molecular Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Interest Income28.4 M27.1 M4.4 M
Slightly volatile
Interest Income28.4 M27.1 M4.4 M
Slightly volatile
Depreciation And Amortization4.2 M6.6 M2.6 M
Slightly volatile
Selling General Administrative25.4 M46.6 M14.7 M
Slightly volatile
Total Revenue35.1 K37 K7.7 M
Pretty Stable
Other Operating Expenses94.7 M187.9 M56.4 M
Slightly volatile
Research Development148.4 M141.3 M46.7 M
Slightly volatile
Total Operating Expenses94.7 M187.9 M56.4 M
Slightly volatile
Reconciled Depreciation7 M6.7 M2.2 M
Slightly volatile
Cost Of Revenue117.2 M111.7 M48.3 M
Slightly volatile
Selling And Marketing Expenses4.6 M5.2 M5.6 M
Slightly volatile

4D Molecular Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation27.4 M26.1 M7.3 M
Slightly volatile
Begin Period Cash Flow261.6 M249.1 M76.3 M
Slightly volatile
Depreciation7 M6.7 M2.2 M
Slightly volatile
Capital Expenditures4.5 M3.8 M2.6 M
Slightly volatile
End Period Cash Flow143.8 M149.3 M84.8 M
Slightly volatile
Change To Netincome20.7 M19.7 M6.7 M
Slightly volatile
Issuance Of Capital Stock348 M331.4 M124.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio8.5 K8.1 K1.1 K
Slightly volatile
Days Sales Outstanding1.041.0917.928
Slightly volatile
Stock Based Compensation To Revenue74170690.9674
Slightly volatile
Capex To Depreciation0.410.431.1945
Pretty Stable
EV To Sales5 K4.7 K686
Slightly volatile
Payables Turnover20.4431.7724.301
Slightly volatile
Sales General And Administrative To Revenue1.3 K1.3 K163
Slightly volatile
Average Inventory0.40.450.4906
Slightly volatile
Research And Ddevelopement To Revenue4 K3.8 K493
Slightly volatile
Capex To Revenue0.110.120.3693
Slightly volatile
Cash Per Share6.37.87635.0321
Slightly volatile
Days Payables Outstanding11.311.8966.9598
Slightly volatile
Net Debt To EBITDA0.630.6642.7044
Very volatile
Current Ratio10.0614.9218.7339
Slightly volatile
Receivables Turnover363345127
Slightly volatile
Capex Per Share0.110.06370.0894
Slightly volatile
Revenue Per Share7.0E-47.0E-40.3939
Pretty Stable
Interest Debt Per Share0.530.45610.5611
Slightly volatile
Debt To Assets0.05370.04390.0475
Slightly volatile
Days Of Payables Outstanding11.311.8966.9598
Slightly volatile
Ebt Per Ebit1.050.85640.977
Slightly volatile
Long Term Debt To Capitalization0.02860.03220.0351
Slightly volatile
Quick Ratio10.1514.9218.7951
Slightly volatile
Net Income Per E B T1.091.081.0464
Slightly volatile
Cash Ratio8.735.12327.7657
Slightly volatile
Days Of Sales Outstanding1.041.0917.928
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.840.930.978
Slightly volatile
Fixed Asset Turnover9.0E-49.0E-41.7628
Slightly volatile
Debt Ratio0.05370.04390.0475
Slightly volatile
Price Sales Ratio8.5 K8.1 K1.1 K
Slightly volatile
Asset Turnover1.0E-41.0E-40.1333
Slightly volatile

4D Molecular Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap285.4 M300.5 M639.4 M
Very volatile
Enterprise Value166.9 M175.7 M526 M
Slightly volatile

FDMT Fundamental Market Drivers

Cash And Short Term Investments424.9 M

FDMT Upcoming Events

20th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About 4D Molecular Financial Statements

4D Molecular shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although 4D Molecular investors may analyze each financial statement separately, they are all interrelated. The changes in 4D Molecular's assets and liabilities, for example, are also reflected in the revenues and expenses on on 4D Molecular's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue257 K244.2 K
Total Revenue37 K35.1 K
Cost Of Revenue111.7 M117.2 M
Stock Based Compensation To Revenue 705.84  741.13 
Sales General And Administrative To Revenue1.3 K1.3 K
Research And Ddevelopement To Revenue3.8 K4 K
Capex To Revenue 0.12  0.11 
Ebit Per Revenue-5.1 K-4.8 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for FDMT Stock Analysis

When running 4D Molecular's price analysis, check to measure 4D Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4D Molecular is operating at the current time. Most of 4D Molecular's value examination focuses on studying past and present price action to predict the probability of 4D Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4D Molecular's price. Additionally, you may evaluate how the addition of 4D Molecular to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY